The funding will reduce waiting lists and ease the demand on the NHS during Winter
News
UKRI report reveals impact of COVID-19 research and innovation funding
The report highlights steps needed to ensure future pandemics are handled effectively
UKRI’s MRC invests £2m for hard-to-treat cancers
Four research innovation teams are set to receive £500,000 each
Eisai launches new digital business company for dementia
Theoria technologies aims to empower those affected by dementia
Defibrillators should be given to high-risk heart failure patients sooner
Around 2.3 million people live with coronary heart disease in the UK
Salipro Biotech and Sumitomo Pharma collaborate for drug discovery
The research will aim to reveal the mechanism of action of a drug target candidate
Orano Med and Orbit Discovery collaborate on radioligand therapies for cancer
Both companies will work to advance the development of novel radiopharmaceuticals
Microplate Dx secures £2.5m for rapid diagnostic technology development
The platform will be used to advance the effectiveness of antibiotics
Brainomix’s e-Lung enters TIPAL trial
The company will use its AI technology during a sub-study to analyse the effect of lansoprazole
AMO Pharma reveals data from myotonic dystrophy study
Clinically significant results have emerged from trial evaluating the company’s AMO-02 candidate
Ariceum doses first patient with satoreotide
The treatment targets extensive stage small cell lung cancer and aims to boost therapeutic impact
Neuroplast spinal cord injury study milestone
The trial analyses the impact of its ‘Neuro-Cells’ among patients with traumatic spinal cord injuries
Bristol Myers Squibb’s Camzyos gets NICE recommendation
Therapy is used among adult patients with symptomatic obstructive hypertrophic cardiomyopathy
Vitestro begins blood-drawing device study
Technology combines AI-based, ultrasound-guided 3D reconstruction with robotic needle insertion
EsoCap finalises recruitment for eosinophilic esophagitis study
Candidate ESO-101 will treat participating patients across five European countries
